Sign Up to like & get
recommendations!
0
Published in 2020 at "mAbs"
DOI: 10.1080/19420862.2020.1812210
Abstract: ABSTRACT Here, we report the characterization of a VHH-derived IgG-like bi- and trispecific antibody platform that essentially relies on the replacement of the VH and VL regions of a conventional antibody by two independently functioning…
read more here.
Keywords:
characterization vhh;
trispecific antibody;
igg like;
like trispecific ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "mAbs"
DOI: 10.1080/19420862.2021.1981806
Abstract: ABSTRACT Fragmentation is a well-characterized degradation pathway of therapeutic antibodies and is usually monitored by capillary electrophoresis–sodium dodecyl sulfate (CE-SDS). Although fragments due to cleavage in CH2 domains linked by intrachain disulfide bonds are common…
read more here.
Keywords:
ch2;
sds;
shoulder peak;
igg like ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "mAbs"
DOI: 10.1080/19420862.2022.2044435
Abstract: ABSTRACT Targeting PD1/PDL1 with blocking antibodies for cancer therapy has shown promising benefits in the clinic, but only approximately 20–30% of patients develop durable clinical responses to the treatment. Bispecific antibodies (BsAbs) that combine PD1/PDL1…
read more here.
Keywords:
igg like;
immune checkpoint;
desired igg;
anti pd1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Immunology Research"
DOI: 10.1155/2019/4516041
Abstract: Bispecific antibodies (BsAbs) are a sort of dual functional proteins with specific binding to two distinct targets, which have become a focus of interest in antibody engineering and drug development research and have a promising…
read more here.
Keywords:
immunoglobulin gamma;
igg like;
antibody;
tumor therapy ... See more keywords